Detection bias most likely explains the association between prostate cancer and history of any CID or use of AIMs, given more frequent contact with the healthcare system would increase the opportunity for prostate cancer detection through blood tests which include PSA measurement. The gene discussed is KLK3; the disease is prostate carcinoma.